Linked Life Data

14655747

Source:http://linkedlifedata.com/resource/pubmed/id/14655747

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2003-12-5
pubmed:abstractText
We conducted a retrospective review of our bridge to transplant experience over the last 7 years using the Heartmate device (Thoratec, Pleasanton, CA) by studying patients who developed device related infections. Of the 174 patients who underwent device implantation, 32 (18.4%) developed a device related infection while on support (12 patients with drive line infections, 14 patients with pocket infections, 4 patients with pump infections, and 2 patients with device endocarditis). There was no significant difference in rate of successful bridging to transplant between patients with and without a device related infection occurring in 23 (71.9%) patients with infection and 103 (72.5%) patients without infection (p = 0.406). In addition, posttransplant survival at 1, 3, and 5 years was similar for both groups--95.6%, 86.2%, and 79.3%, respectively, for patients with infection, versus 90.9%, 88.1%, and 82.2%, respectively, for patients without infection (p = 0.911).
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:issn
1058-2916
pubmed:author
pubmed:issnType
Print
pubmed:volume
49
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
748-50
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed:articleTitle
Device related infections while on left ventricular assist device support do not adversely impact bridging to transplant or posttransplant survival.
pubmed:affiliation
Department of Surgery, Division of Cardiothoracic Surgery, College of Physicians and Surgeons, Columbia University, Milstein Hospital 7GN-435, New York, NY 10032, USA.
pubmed:publicationType
Journal Article